The presence of pulmonary hypertension may independently predict poor short- and long-term outcomes after transcatheter aortic valve replacement in patients with severe aortic stenosis, researchers reported in The American Journal of Cardiology.

The researchers reported an early overall increase in SPAP after TAVR; however, only 26% of patients with moderate/severe pulmonary hypertension experienced a significant decrease in post-procedure SPAP greater than 10 mm Hg.